Info: 60 Capsules
AOR's Migraine Manager formulation contains a blend of five vitamins, minerals and botanicals that work together to alleviate migraine headaches.
Info: 60 Capsules
AOR's Migraine Manager formulation contains a blend of five vitamins, minerals and botanicals that work together to alleviate migraine headaches.
Product Notes:
The first ingredient, Vinpocetine, is an extract derived from the periwinkle plant that increases cerebral circulation, which can improve the symptoms of migraines and improve cognitive function. Riboflavin (Vitamin B2) has been demonstrated in double-blind placebo controlled studies to reduce the intensity of migraines by half. Rosemary has been traditionally used to relieve headaches, this formulation contains 75 mg of rosemary extract. Feverfew is one of the more well-known herbs for migraines, with its efficacy being supported by multiple studies. Finally, this formula also contains magnesium citrate, since low levels of magnesium are correlated with a higher incidence of migraines.
Migraine Manager Ingredients:
Each 257.5 mg capsule contains:
Vinpocetine: 7.5 mg
Riboflavin: 100 mg
Rosmarinus officinalis extract (5:1; DHE 375 mg dry): 75 mg
Tanacetum parthenium (Feverfew) extract (0.2% Parthenolide): 25 mg
Magnesium (Magnesium Citrate): 50 mg
Non-medicinal ingredients: Microcrystalline cellulose, Maltodextrin, Gum Arabic, Sodium stearyl fumarate, Tapioca, and Silica. Capsule: hypromellose.
Part of AOR's Advanced Series, Migraine Manager is a vegan, non-GMO, and gluten-free product. AOR guarantees that all ingredients have been declared on the label.
Suggested Usage:
Do not crush, blend, or mix the capsules -- swallow them whole.
Dosage: Adults: Take two capsules, one to two times daily with food, or as directed by a healthcare practitioner. For cognitive health: Take two capsules, two time a day. Use for a minimum of 4 to 6 weeks to see beneficial effects. Consult a healthcare practitioner for use beyond six months. Reduce the dosage gradually if the treatment is to be paused or discontinued.
Warnings:
Do not take Migraine Manager if you are pregnant or breastfeeding, or allergic to plants of the Asteraceae/Compositae/Daisy family. Consult a healthcare practitioner prior to use if you: are taking blood thinners; have high or low blood pressure, cardiac arrhythmia, or dementia; or have suffered a stroke. Consult a health care practitioner if symptoms persist or worsen. Discontinue use and consult a health care practitioner if you experience heart palpitations. Hypersensitivity, such as allergy, is known to occur; in which case, discontinue use. Some people may experience anxiety; in which case, discontinue use. Some people may experience gastrointestinal discomfort, dizziness or headaches; in which case, discontinue use. Some people may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort. Some people may experience diarrhoea.
Health Canada Natural Product Number: 80092738.
Supporting Science:
“An update on vinpocetine: New discoveries and clinical implications.” European Journal of Pharmacology, 2018.
“Anti-Inflammatory and Neuromodulatory Effects Induced by Tanacetum parthenium Water Extract: Results from In Silico, In Vitro and Ex Vivo Studies.” Molecules (Basel, Switzerland), 2020.
“Energy metabolism disturbance in migraine: From a mitochondrial point of view.” Frontiers in Physiology, 2023.
“Magnesium as an Important Factor in the Pathogenesis and Treatment of Migraine-From Theory to Practice.” Nutrients, 2022.
“Natural Herbal Non-Opioid Topical Pain Relievers-Comparison with Traditional Therapy.” Pharmaceutics, 2022.
“Nutraceuticals and migraine: further strategy for the treatment of specific conditions.” Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022.
“Prophylaxis of migraine headaches with riboflavin: A systematic review.” Journal of Clinical Pharmacy and Therapeutics, 2017.
“Tanacetum species: Bridging empirical knowledge, phytochemistry, nutritional value, health benefits and clinical evidence.” Frontiers in Pharmacology, 2023.
“The Role of Magnesium in Pathophysiology and Migraine Treatment.” Biological Trace Element Research, 2020.
“Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders.” Iranian Journal of Basic Medical Sciences, 2020.
“Vinpocetine (A comprehensive profile).” Profiles of Drug Substances, Excipients, and Related Methodology 2022.